ReviewEClinicalMedicine2024

International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.

Robert Samuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.